At SOT 2017: New Applications of NHR assays in TOX
Through our key collaborations with U.S. EPA, NIH and Bayer, notable applications of PamGene's Nuclear receptor assay in advancing the Toxicology field were presented, in a lecture and poster at this year's Society of Toxicology Meeting.

Lecture: Tuesday Morning, March 14, 9:30 AM to 12:15 PM, CC Room 308
Platform Session: Endocrine Toxicology
Abstract 1636   
11:02 AM
Identification of Androgen Receptor Antagonists Using Tox21 qHTS Data and the MARCoNI Assay.
A. Bone1, M. Xia2, S. Sakamuru2, R. Huang2, R. Houtman3, R. van Beuningen3, E. Watt1, N. Kleinstreuer4, R. Judson1, and K. Houck1. 1US EPA, Research Triangle Park, NC; 2National Center for Advancing Translational Sciences (NIH), Rockville, MD; 3Pamgene, Hertogenbosch, Netherlands; and 4NTP Interagency Center for the Evaluation of Alternative Toxicological Methods (NIH), Research Triangle Park, NC.

Poster: Monday Afternoon, March 13 1:15 PM to 4:30 PM CC Exhibit Hall
Poster Session: Endocrine Toxicology
Displayed: 1:15 PM–4:30 PM; Author Attended: 1:15 PM–2:45 PM 
Abstract 1500   
Poster Board No. P509
Identification of Novel Chemical Modulators of Estrogen Receptor α (ERα) in a Gene
Expression Compendium.
J. Rooney1, N. Ryan2, R. Houtman3, R. van Beuningen3, J. Hsieh4, S. Chen5, and J.C. Corton1. 1US EPA, Durham, NC; 2Bayer Crop Science, Durham, NC; 3Pamgene, Hertogenbosch, Netherlands; 4NIH, Bethesda, MD; and 5City of Hope Medical Center, Duarte, CA.
For more information, please contact PamGene's Managing Director John Groten: 
Email John